- Home
- YJ vs HCWB Comparison
YJ vs HCWB Comparison
Compare YJ & HCWB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YJ
- HCWB
- Stock Information
- Founded
- YJ 2015
- HCWB 2018
- Country
- YJ China
- HCWB United States
- Employees
- YJ N/A
- HCWB N/A
- Industry
- YJ Other Specialty Stores
- HCWB Biotechnology: Pharmaceutical Preparations
- Sector
- YJ Consumer Discretionary
- HCWB Health Care
- Exchange
- YJ Nasdaq
- HCWB Nasdaq
- Market Cap
- YJ 10.1M
- HCWB 10.8M
- IPO Year
- YJ 2019
- HCWB 2021
- Fundamental
- Price
- YJ $1.74
- HCWB $5.72
- Analyst Decision
- YJ
- HCWB Strong Buy
- Analyst Count
- YJ 0
- HCWB 1
- Target Price
- YJ N/A
- HCWB $35.00
- AVG Volume (30 Days)
- YJ 9.6K
- HCWB 4.5M
- Earning Date
- YJ 08-21-2025
- HCWB 08-18-2025
- Dividend Yield
- YJ N/A
- HCWB N/A
- EPS Growth
- YJ N/A
- HCWB N/A
- EPS
- YJ N/A
- HCWB N/A
- Revenue
- YJ $47,760,127.00
- HCWB $832,841.00
- Revenue This Year
- YJ N/A
- HCWB $178.36
- Revenue Next Year
- YJ N/A
- HCWB N/A
- P/E Ratio
- YJ N/A
- HCWB N/A
- Revenue Growth
- YJ N/A
- HCWB N/A
- 52 Week Low
- YJ $1.37
- HCWB $2.77
- 52 Week High
- YJ $2.73
- HCWB $100.80
- Technical
- Relative Strength Index (RSI)
- YJ 48.10
- HCWB 64.83
- Support Level
- YJ $1.67
- HCWB $5.47
- Resistance Level
- YJ $1.75
- HCWB $6.66
- Average True Range (ATR)
- YJ 0.06
- HCWB 0.68
- MACD
- YJ 0.00
- HCWB 0.24
- Stochastic Oscillator
- YJ 40.91
- HCWB 64.41
About YJ Yunji Inc. American Depository Shares
Yunji Inc is a social e-commerce platform in China that offers a membership-based model that leverages the power of social interaction. The company provides a host of selected commodities such as beauty and personal care, mobile phones and digital products, baby and maternal products, toys, fruits, and other fresh products. It has expanded to operate its business, including the marketplace, on a diverse range of sales channels and other platforms. Geographically, the firm operates in the PRC.
About HCWB HCW Biologics Inc.
HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.